We are very excited to share our feature article in Nature Portfolio.
Titled, “Breakthrough Technologies Transform the Discovery and Development of Peptide Drugs.” The article looks at how Pepticom designs ab initio novel peptide drug candidates using proprietary AI-driven biocomputational software. You can read the whole article here:https://lnkd.in/gc3G-Shh #drugdiscovery #artificialintelligence #drugdiscovery
WE ARE HIRING – A Research Assistant
We are looking for a highly motivated research assistant to join our team in the field of peptide-based drug discovery. Responsibilities:ยท Design and perform drug screening assayยท Assistance in design and execution of various biological research methods frombiochemistry to cell-based assaysยท Reviewing the current literature and participating in scientific discussion APPLY HERE: https://lnkd.in/eyCMzrvB
๐ฃ๐๐ฃ๐ง๐๐๐ข๐ ๐ถ๐ ๐ต๐ถ๐ฟ๐ถ๐ป๐ด ๐ฎ๐ป ๐ข๐ฃ๐๐ฅ๐๐ง๐๐ข๐ก๐ฆ ๐ ๐๐ก๐๐๐๐ฅ
A stellar operations manager with 5+ years of operations experience with cross-functional teams. We offer an amazing opportunity to grow within a growth stage company that is building a promising technology and changing the world. https://lnkd.in/eFgx9vRw #Peptide #DrugDiscovery #AI
๐๐ ๐๐ง๐ ๐๐๐ง๐๐ฃ๐ ๐ ๐พ๐๐๐๐๐๐ผ๐๐๐๐๐ผ๐ ๐พ๐๐๐๐๐๐.
A Scientist who specializes in proteins and peptide structures not informatics, and who can manage and operate discovery projects for collaborations and for in-house projects. See full job description in the below ๐ link:https://lnkd.in/dTK4Bcm5
Immanuel our CEO will be coming to Boston
an exciting joint venture between Harvard Business School and 8400 – The Health Network. He will be available for meetings on November 2-5. Please be in touch with Immanuel Lerner, Ph.D. or Maayan Elias Robicsek for meeting or collaboration opportunities.
Wishing all our followers, friends, families and colleagues a SWEET and Happy Jewish New Year.
ืฉื ื ืืืื ๐ฏ๐
We are thrilled to announce that Dr. Tomi Sawyer, a world leading Key Opinion Leader (KOL) in the field of peptide #drugdiscovery, will be joining the Pepticom Ltd. Scientific Board.
Tomi is renowned for the discovery of two FDA-approved drugs, including Scenesseยฎ๏ธ (marketed by Clinuvel) and Iclusigยฎ๏ธ (marketed by Takeda) as well as scientific contribution to the design of macrocyclic peptides, including ALRN-6924 (currently in Phase II clinical trials by Aileron Therapeutics). Tomi has also been credited with ~600 scientific publications, patents, and presentations and […]
With over 6,000 active Israeli startups in the #startupnation
Each and every mention and recognition we receive is an honor. Thank you toย 2Scots – Marketing for Israeli Startupsย andย Darren Gladstoneย for featuring Pepticom in their roundup of 100 Startups. You can read more about this amazing project here:https://lnkd.in/eVaJKRV
Pepticom is #hiring A Scientist.
๐ฅ๐ฒ๐๐ฝ๐ผ๐ป๐๐ถ๐ฏ๐ถ๐น๐ถ๐๐ถ๐ฒ๐:-> Managing the research from basic biochemistry to cell-based assays abreast executing and oversees the scientific activities of the company.-> Wide-ranging understanding in the contemporary SARS-COV-2 literature, with comprehensive understanding of the basic science.-> Establishing and coordinating outsourced activities with CROs.-> Managing the project work plan and establishing and coordinating outsourced activities with CROs. ๐๐ฎ๐ป๐ฑ๐ถ๐ฑ๐ฎ๐๐ฒ๐ […]
Deep Pharma Intelligence just released this ๐๐ซ๐ญ๐ข๐๐ข๐๐ข๐๐ฅ ๐๐ง๐ญ๐๐ฅ๐ฅ๐ข๐ ๐๐ง๐๐ ๐ข๐ง ๐๐ซ๐ฎ๐ ๐๐ข๐ฌ๐๐จ๐ฏ๐๐ซ๐ฒ: ๐ ๐จ๐๐ฎ๐ฌ ๐จ๐ง ๐๐ง๐๐จ๐ฅ๐จ๐ ๐ฒ report
which features @Pepticom among an amazing ecosystem of biotech companies and technology developers who are applying advanced data analytics and knowledge extraction technologies to drug discovery. Thank you for including us! You can access it via the link: https://lnkd.in/d7pDUwQ